SlideShare a Scribd company logo
1 of 16
ANTIVIRAL AGENTS
Farman Ahmad
Department of pharmaceutical sciences & natural products (cupb)
CONTENT
•Introduction
•Classification
•Structure Activity Relationship (SAR)
Introduction
Anti-viral- Anti=against, Viral=Infection caused by Virus
Antiviral agents are the drugs which are developed to effectively treat an
infection caused by a virus
Virus is a submicroscopic infectious agent (pathogen) that replicates only
inside living cells
Typically a virus consist a segment of nucleic acid(DNA or RNA) surrounded by
a protein coat
Virus can infect all forms of life from animal and plants to microorganisms
CLASSIFICATION
Based on Virus:-
Non-
Retrovirus
Anti-
Hepatitis
Hepatitis B
Lamivudin
Adefovir
dipivoxil
Tenofovir
Hepatitis C
Ribavirin
Interferon alpha
Anti-
Influenza
Amantadine
Rimantadine
Oseltamivir
Zanamivir
Anti-
Herpes
Idoxuridine
Trifluridine
Acyclovir
Valacyclovir
Famciclovir
Ganciclovir
Valganciclovir
Cidofovir
Foscarnet
Fomivirsen
CLASSIFICATION
Based on Virus:-
Retrovirus
Nucleoside
reverse
transcriptas
e inhibitors
Zidovudine
Didanosine
Stavudine
Lamivudine
Abacavir
Emtricitabine
Tenofovir
Non-
nucleoside
reverse
transcriptas
e inhibitors
Nevirapine
Efavirenz
Delavirdine
Protease
inhibitors
Ritonavir
Atazanavir
Indinavir
Nelfinavir
Saquinavir
Amprenavir
Lopinavir
Entry
inhibitor
Enfuvirtide
CCR-5
receptor
inhibitor
Maraviroc
Integrase
Inhibitor
Raltegravir
CLASSIFICATION
Based on Chemical Nature:-
Admantane Derivatives:-
Amantadine, Rimantadine, Somantadine, Tromantadine.
Purine Analogue:-
Acyclovir, Ganciclovir, Vidarabine, Valaciclovir, Penciclovir
Pyrimidine Analogue:-
Trifluridine, Idoxuridine, Zidovudine, Stavudine, Emtricitabine
Phosphorus Derivatives:-
Foscarnet, Tenofovir
Thiazolides:-
Nitazoxanide
Chemical Structures
Mechanism of action:-
1. Purine Analogue
Mechanism of action:-
2. Admantane derivatives
Inhibit viral replication by blocking the proton channel formed by the M2 protein
of influenza A virus.
The channel activity is necessary for viral particle un-coating during early and late
stages of viral replication.
Mechanism of action:-
3. Pyrimidine analogue:-
Iodinated thymidine analog, activated intra-cellularly to tri-phosphate which
can inhibit DNA polymerases required for incorporation of thymidine into viral
DNA.
Idoxuridine, instead of thymidine, is incorporated into viral DNA, resulting in
faulty DNA and the inability of the virus to infect tissue or reproduce.
Structure Activity Relationship(SAR)
Acyclovir:-
Acyclic side chain at N-9 is essential for
anti-viral activity
Removal of –CH2OH group from side
chain, inactive analogue obtained
The 9-alkoxy derivative is highly active
against Simplex and Vericella zoster
virus, obtained by slight modification at
acyl side chain
Acyclovir V/S Ganciclovir
 Ganciclovir differ from acyclovir by a single carboxyl side chain
 Ganciclovir 50 times more potent than acyclovir against
CMV(Cytomegalovirus) due to absence of thymidine kinase in CMV.
 Ganciclovir not require phosphorylation for producing its action against
CMV.
Acyclovir V/S Vidarabin
 The use of vidarabine was replaced by acyclovir because of poor solubility
and toxicity for herpes simplex virus infection.
 The mortality rate was found to be 19% for acyclovir and 50% for vidarabin
Acyclovir V/S Penciclovir
 Penciclovir has a higher affinity for HSV TK than acyclovir
 the levels of penciclovir triphosphate in infected cells are much higher
than the levels of acyclovir triphosphate
.

More Related Content

Similar to ANTIVIRAL AGENTS.pptx

Antiviral Chemotherapy
Antiviral ChemotherapyAntiviral Chemotherapy
Antiviral Chemotherapy
raj kumar
 
Antiviral Drugs & MOA Presentation .pptx
Antiviral Drugs & MOA Presentation .pptxAntiviral Drugs & MOA Presentation .pptx
Antiviral Drugs & MOA Presentation .pptx
St. John Institute of Pharmacy & Research
 

Similar to ANTIVIRAL AGENTS.pptx (20)

antiviral drugs
antiviral drugsantiviral drugs
antiviral drugs
 
Antiviral Drugs.pptx
Antiviral Drugs.pptxAntiviral Drugs.pptx
Antiviral Drugs.pptx
 
4517 anti viral drugs1
4517 anti viral drugs14517 anti viral drugs1
4517 anti viral drugs1
 
3rd_antiviral_3.ppt
3rd_antiviral_3.ppt3rd_antiviral_3.ppt
3rd_antiviral_3.ppt
 
Antiviral Chemotherapy
Antiviral ChemotherapyAntiviral Chemotherapy
Antiviral Chemotherapy
 
Antiviral Agents.pptx
Antiviral Agents.pptxAntiviral Agents.pptx
Antiviral Agents.pptx
 
Anti viral
Anti viralAnti viral
Anti viral
 
Scientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and geneticsScientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and genetics
 
Anti viral drugs
Anti viral drugsAnti viral drugs
Anti viral drugs
 
Antiviral Drugs ppt
Antiviral Drugs pptAntiviral Drugs ppt
Antiviral Drugs ppt
 
Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents
 
Antiviraldrugs
AntiviraldrugsAntiviraldrugs
Antiviraldrugs
 
Antiviral Drugs -1
Antiviral Drugs -1Antiviral Drugs -1
Antiviral Drugs -1
 
Antiviral Drugs & MOA Presentation .pptx
Antiviral Drugs & MOA Presentation .pptxAntiviral Drugs & MOA Presentation .pptx
Antiviral Drugs & MOA Presentation .pptx
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Antiviral
AntiviralAntiviral
Antiviral
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Antivirals
Antivirals Antivirals
Antivirals
 
14. antiviral drugs
14. antiviral drugs14. antiviral drugs
14. antiviral drugs
 
ANTIVIRAL DRUGS lecture notes in ppt format
ANTIVIRAL DRUGS  lecture notes in ppt formatANTIVIRAL DRUGS  lecture notes in ppt format
ANTIVIRAL DRUGS lecture notes in ppt format
 

Recently uploaded

SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
CaitlinCummins3
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
中 央社
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
中 央社
 

Recently uploaded (20)

Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community PartnershipsSpring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportBasic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in Hinduism
 
ANTI PARKISON DRUGS.pptx
ANTI         PARKISON          DRUGS.pptxANTI         PARKISON          DRUGS.pptx
ANTI PARKISON DRUGS.pptx
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjjStl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopal
 
ESSENTIAL of (CS/IT/IS) class 07 (Networks)
ESSENTIAL of (CS/IT/IS) class 07 (Networks)ESSENTIAL of (CS/IT/IS) class 07 (Networks)
ESSENTIAL of (CS/IT/IS) class 07 (Networks)
 
PSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptxPSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptx
 

ANTIVIRAL AGENTS.pptx

  • 1. ANTIVIRAL AGENTS Farman Ahmad Department of pharmaceutical sciences & natural products (cupb)
  • 3. Introduction Anti-viral- Anti=against, Viral=Infection caused by Virus Antiviral agents are the drugs which are developed to effectively treat an infection caused by a virus Virus is a submicroscopic infectious agent (pathogen) that replicates only inside living cells Typically a virus consist a segment of nucleic acid(DNA or RNA) surrounded by a protein coat Virus can infect all forms of life from animal and plants to microorganisms
  • 4. CLASSIFICATION Based on Virus:- Non- Retrovirus Anti- Hepatitis Hepatitis B Lamivudin Adefovir dipivoxil Tenofovir Hepatitis C Ribavirin Interferon alpha Anti- Influenza Amantadine Rimantadine Oseltamivir Zanamivir Anti- Herpes Idoxuridine Trifluridine Acyclovir Valacyclovir Famciclovir Ganciclovir Valganciclovir Cidofovir Foscarnet Fomivirsen
  • 5. CLASSIFICATION Based on Virus:- Retrovirus Nucleoside reverse transcriptas e inhibitors Zidovudine Didanosine Stavudine Lamivudine Abacavir Emtricitabine Tenofovir Non- nucleoside reverse transcriptas e inhibitors Nevirapine Efavirenz Delavirdine Protease inhibitors Ritonavir Atazanavir Indinavir Nelfinavir Saquinavir Amprenavir Lopinavir Entry inhibitor Enfuvirtide CCR-5 receptor inhibitor Maraviroc Integrase Inhibitor Raltegravir
  • 6.
  • 7. CLASSIFICATION Based on Chemical Nature:- Admantane Derivatives:- Amantadine, Rimantadine, Somantadine, Tromantadine. Purine Analogue:- Acyclovir, Ganciclovir, Vidarabine, Valaciclovir, Penciclovir Pyrimidine Analogue:- Trifluridine, Idoxuridine, Zidovudine, Stavudine, Emtricitabine Phosphorus Derivatives:- Foscarnet, Tenofovir Thiazolides:- Nitazoxanide
  • 9. Mechanism of action:- 1. Purine Analogue
  • 10. Mechanism of action:- 2. Admantane derivatives Inhibit viral replication by blocking the proton channel formed by the M2 protein of influenza A virus. The channel activity is necessary for viral particle un-coating during early and late stages of viral replication.
  • 11. Mechanism of action:- 3. Pyrimidine analogue:- Iodinated thymidine analog, activated intra-cellularly to tri-phosphate which can inhibit DNA polymerases required for incorporation of thymidine into viral DNA. Idoxuridine, instead of thymidine, is incorporated into viral DNA, resulting in faulty DNA and the inability of the virus to infect tissue or reproduce.
  • 12. Structure Activity Relationship(SAR) Acyclovir:- Acyclic side chain at N-9 is essential for anti-viral activity Removal of –CH2OH group from side chain, inactive analogue obtained The 9-alkoxy derivative is highly active against Simplex and Vericella zoster virus, obtained by slight modification at acyl side chain
  • 13. Acyclovir V/S Ganciclovir  Ganciclovir differ from acyclovir by a single carboxyl side chain  Ganciclovir 50 times more potent than acyclovir against CMV(Cytomegalovirus) due to absence of thymidine kinase in CMV.  Ganciclovir not require phosphorylation for producing its action against CMV.
  • 14. Acyclovir V/S Vidarabin  The use of vidarabine was replaced by acyclovir because of poor solubility and toxicity for herpes simplex virus infection.  The mortality rate was found to be 19% for acyclovir and 50% for vidarabin
  • 15. Acyclovir V/S Penciclovir  Penciclovir has a higher affinity for HSV TK than acyclovir  the levels of penciclovir triphosphate in infected cells are much higher than the levels of acyclovir triphosphate
  • 16. .